DTC advertising gets a wrist slap from the FDA
“The majority of the FDA advisory panel on cox-2 inhibitors, drugs that include Bextra, Celebrex, and Vioxx, called for a ban on all cox-2 advertising. The agency is unlikely to follow that recommendation. ‘Such a ban would be almost certainly illegal. The FDA has no statutory authority to ban advertising. Even if it were to have such authority, such a ban would almost certainly be unconstitutional,’ said Daniel Troy, the FDA’s former chief counsel.”
